pamidronate has been researched along with Femoral Fractures in 11 studies
Femoral Fractures: Fractures of the femur.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The multidisciplinary, rational approach, which involves early surgical intramedullary fixation of fractures with subsequent rehabilitation and Pamidronate administration, is considered to provide a more effective therapy with better results and therefore better quality of life in patients with osteogenesis imperfecta." | 3.74 | [Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta]. ( Kokavec, M; Novorolský, K; Pribilincová, Z, 2008) |
| " At this point, closed fractures were made using an Einhorn apparatus, and bisphosphonate dosing was continued until the experimental endpoint." | 1.56 | Pretreatment with Pamidronate Decreases Bone Formation but Increases Callus Bone Volume in a Rat Closed Fracture Model. ( Little, DG; McDonald, MM; Mikulec, K; Morse, A; Munns, CF; Schindeler, A, 2020) |
| "Pamidronate was discontinued after 7 years of therapy, following which she sustained two further nontraumatic femur fractures, and continued to show delayed tibial osteotomy healing." | 1.43 | Recurrent Proximal Femur Fractures in a Teenager With Osteogenesis Imperfecta on Continuous Bisphosphonate Therapy: Are We Overtreating? ( Bishop, NJ; Högler, W; Sanghrajka, A; Vasanwala, RF, 2016) |
| " These traceable BPs were dosed to Wistar rats in models of normal growth and closed fracture repair." | 1.42 | PTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats. ( Cantrill, LC; Little, DG; Mikulec, K; Murphy, CM; Peacock, L; Schindeler, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Morse, A | 1 |
| McDonald, MM | 1 |
| Mikulec, K | 2 |
| Schindeler, A | 2 |
| Munns, CF | 1 |
| Little, DG | 3 |
| Chen, Y | 1 |
| Sebag, M | 1 |
| Powell, TI | 1 |
| Morin, SN | 1 |
| Kumar, G | 1 |
| Dunlop, CC | 1 |
| Murphy, CM | 1 |
| Cantrill, LC | 1 |
| Peacock, L | 1 |
| Palomo, T | 1 |
| Fassier, F | 1 |
| Ouellet, J | 1 |
| Sato, A | 1 |
| Montpetit, K | 1 |
| Glorieux, FH | 1 |
| Rauch, F | 1 |
| Vasanwala, RF | 1 |
| Sanghrajka, A | 1 |
| Bishop, NJ | 2 |
| Högler, W | 1 |
| Menzdorf, L | 1 |
| Weuster, M | 1 |
| Klüter, T | 1 |
| Brüggemann, S | 1 |
| Behrendt, P | 1 |
| Fitchen-Oestern, S | 1 |
| Varoga, D | 1 |
| Seekamp, A | 1 |
| Purcz, N | 1 |
| Glueer, CC | 1 |
| Pufe, T | 1 |
| Lippross, S | 1 |
| Kokavec, M | 1 |
| Novorolský, K | 1 |
| Pribilincová, Z | 1 |
| Arundel, P | 1 |
| Offiah, A | 1 |
| Kumar, D | 1 |
| Kumar, V | 1 |
| Howman-Giles, RB | 1 |
| Wong, E | 1 |
| Ali, SO | 1 |
| Ward, KA | 1 |
| Adams, JE | 1 |
| Freemont, TJ | 1 |
| Mughal, MZ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Intraoperative Use of Tranexamic Acid in Reducing Blood Loss During Telescoping Nail Application in Osteogenesis Imperfecta - Randomized Control Trials[NCT05321199] | 20 participants (Actual) | Interventional | 2022-05-01 | Completed | |||
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 other studies available for pamidronate and Femoral Fractures
| Article | Year |
|---|---|
Pretreatment with Pamidronate Decreases Bone Formation but Increases Callus Bone Volume in a Rat Closed Fracture Model.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bony Callus; Disease Model | 2020 |
Atypical femur fracture in a woman with osteogenesis imperfecta and multiple myeloma.
Topics: Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Humans; Middle Aged; Mu | 2018 |
Effects of bilateral distal femoral stress in a patient on long-term pamidronate.
Topics: Accidental Falls; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fract | 2013 |
PTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats.
Topics: Animals; Carbon Isotopes; Diphosphonates; Femoral Fractures; Fracture Healing; Imidazoles; Isotope L | 2015 |
Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Topics: Absorptiometry, Photon; Adolescent; Anthropometry; Bone and Bones; Bone Density; Bone Density Conser | 2015 |
Recurrent Proximal Femur Fractures in a Teenager With Osteogenesis Imperfecta on Continuous Bisphosphonate Therapy: Are We Overtreating?
Topics: Adolescent; Child; Child, Preschool; Diphosphonates; Female; Femoral Fractures; Humans; Osteogenesis | 2016 |
Local pamidronate influences fracture healing in a rodent femur fracture model: an experimental study.
Topics: Animals; Bone Density Conservation Agents; Collagen; Diphosphonates; Disease Models, Animal; Female; | 2016 |
[Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta].
Topics: Adolescent; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Femor | 2008 |
Evolution of the radiographic appearance of the metaphyses over the first year of life in type V osteogenesis imperfecta: clues to pathogenesis.
Topics: Arm Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cranial Fontanelles; Diphosph | 2011 |
Evaluation of biodistribution by local versus systemic administration of 99mTc-labeled pamidronate.
Topics: Administration, Topical; Animals; Bone Density Conservation Agents; Diphosphonates; Disease Models, | 2006 |
Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?
Topics: Accidental Falls; Bone Density; Bone Density Conservation Agents; Child, Preschool; Diphosphonates; | 2007 |